BridgeMD
New treatment option for Teenagers
Official title Visual and Postural Behavior in Myopic and Non-Myopic Teenagers
ClinicalTrials.gov ID: NCT07440134
What this study is testing
- What it's testing
- The goal of this observational study is to learn whether different types of eyeglasses prescription and different types of lenses change how close teenagers hold objects when looking at them up close. The study includes adolescents who are non-myopic and adolescents who are myopic and wear either single-vision lenses or lenses slowing down myopia progression.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 17. Healthy volunteers may be eligible.
You may be able to join if
- Volunteer adolescent, fluent in French, able to follow protocol and read and write
- Aged between 12 and 17 years and 6 months
- Adolescent with no history, according to the participant and/or their legal representatives, of any pathology, deficit, or disorder that could...
- If the subject wears glasses, they must have an ophthalmic prescription dated within the last year, certifying that a consultation was carried out...
- If the subject wears Essilor® Stellest® 1.0 lenses, they must have worn them for at least two (2) consecutive months prior to inclusion in the study.
You likely can't join if
- Age ≤ 12 years
- Age \> 17 years and 6 months
- Pregnant or breastfeeding women (Article L1121-5)
- Persons (legal representatives or people) deprived of their liberty by a judicial or administrative decision and persons hospitalized without consent...
- Participants who are currently excluded from another study
- All categories of persons who are particularly protected under French law are excluded from this research (Articles L1121-5 to L1121-9 of the Public...
See the full eligibility criteria
- Volunteer adolescent, fluent in French, able to follow protocol and read and write
- Aged between 12 and 17 years and 6 months
- Adolescent with no history, according to the participant and/or their legal representatives, of any pathology, deficit, or disorder that could interfere with visual or cognitive functions.
- If the subject wears glasses, they must have an ophthalmic prescription dated within the last year, certifying that a consultation was carried out during the previous year
- If the subject wears Essilor® Stellest® 1.0 lenses, they must have worn them for at least two (2) consecutive months prior to inclusion in the study.
- If the subject is nearsighted: -6.5D ≤ equivalent sphere ≤ -0.5D with usual correction
- If the subject is not nearsighted: -0.5 \< equivalent sphere ≤ +2.5
- Age ≤ 12 years
- Age \> 17 years and 6 months
- Pregnant or breastfeeding women (Article L1121-5)
- Persons (legal representatives or people) deprived of their liberty by a judicial or administrative decision and persons hospitalized without consent pursuant to Articles L. 3212-1 and L. 3213-1 who are not covered by...
- Participants who are currently excluded from another study
- All categories of persons who are particularly protected under French law are excluded from this research (Articles L1121-5 to L1121-9 of the Public Health Code)
- Declared neurological deficit, in particular a history of epileptic pathology or sensorimotor coordination disorders, vestibular or cerebellar pathology (e.g., balance disorders)
- Severe declared eye disease involving loss of visual field, such as glaucoma, involving loss of acuity and severe discomfort in low-light or overly bright environments, such as retinitis pigmentosa, or declared and...
- Gougerot-Sjögren syndrome or declared dry eye syndrome
- Declared aphakia or pseudophakia (intraocular implant)
- Declared systemic pathology, medical treatment, or medication with an effect on vision
- People with declared muscle paralysis
- Binocular vision problems such as amblyopia, strabismus, or nystagmus
- Children of employees or employees of Essilor International, Luxottica, GrandVision, and their subsidiaries
- Individuals who have undergone previous refractive surgery, have a history of strabismus surgery, or have a history of any type of eye surgery
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 17 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.